Skip to main content
. Author manuscript; available in PMC: 2018 Jan 20.
Published in final edited form as: ACS Chem Biol. 2016 Dec 16;12(1):282–290. doi: 10.1021/acschembio.6b00791

Figure 1.

Figure 1

Small-angle X-ray scattering from the coformulated colloids supporting a more homogeneous population of particles. (A) SAXS scattering profiles of Sor/CR colloids at three different concentrations within q range of 0.028–1 Å−1. SAXS scattering profiles of Sor/CR (25:1, 1000 μM sorafenib), Sor/CR (25:1, 500 μM sorafenib), and Sor/CR (25:1, 50 μM sorafenib) are in cyan, brown, and orange, respectively. (B) McSAS anaylsis of SAXS scattering profile of Sor/CR (25:1, 1000 μM sorafenib) colloids using only the first 170 data points. (C) Guinier analysis using only data points 2–6 of all three scattering profiles to obtain radius of gyration. All spectra taken in 50 mM KPi, pH 7.0.